We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Daily Rapid Lateral Flow COVID-19 Tests for Traced Contacts for Five Days Could Replace Requirement to Quarantine, Reveals Study

By LabMedica International staff writers
Posted on 25 Jan 2021
Additional testing with either a PCR or lateral flow antigen (LFA) test could potentially reduce the quarantine time of contacts of a confirmed case to seven days from the WHO recommended 14-day quarantine period without raising the risk of onward transmission, according to a new modeling study.

Researchers at the London School of Hygiene & Tropical Medicine (LSHTM; London, UK) conducted the study using mathematical modeling to estimate the effect of different quarantine and testing strategies on reducing onward transmission from traced secondary infections. The team simulated the levels of virus an infected person would be likely to produce at each stage of infection, alongside timing of symptom onset, test sensitivity and tracing and testing timings. The team estimate that completing the full 14-day recommended quarantine period for contacts of COVID-19 cases could prevent 59% of onward virus transmission. A similar proportion of onward transmission could potentially be prevented with only seven days of quarantine if a PCR or LFA test is performed on the final day of quarantine and people who receive a negative result are released.

The study estimates that the quarantine period could be replaced if traced contacts are required to take a daily LFA test for five days and those who do not receive any positive results are released, with 50% of onward virus transmission predicted to be prevented. If people adhere perfectly to self-isolation for the recommended 14 days after a positive test, and their close contacts taking a daily LFA test for five days and are then released on the final day if all tests are negative, the model estimates 80% of onward virus transmission could potentially be averted. Notably, the model is based on the assumption that the LFA test works at the higher level of sensitivity, detecting on average 76.8% of cases that tested positive in a PCR test.

“Our findings suggest that introducing testing of contacts in contact tracing may allow for a large reduction in the duration of quarantine,” said Billy Quilty, joint-lead author and Research Assistant at LSHTM. “Daily rapid tests for at least five days may allow for the quarantine requirement to be removed entirely, with self-isolation required only upon the onset of symptoms or a positive rapid test result. This strategy may allow for critical essential workers to continue working if exposed but not infected.”

Related Links:
London School of Hygiene & Tropical Medicine (LSHTM)


Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.